Skip to content

APOTHEEK GEDOPT: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK GEDOPT

BE 0445.332.146
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€162,059
2024 · €174,279-€12,221
Equity
€409,257
2024 · €247,198+€162,059
Cash
€240,834
2024 · €156,482+€84,351
Balance sheet total
€1.6m
2024 · €1.6m+€34,393

Largest movements

2024 to 2025
Assets
  • Cash +€84,351

    up €84,351 (+53.9%), from €156,482 to €240,834

    mainly Net result for the year (+€162,059) and Depreciation (+€61,655)

  • Tangible fixed assets -€51,887

    down €51,887 (-5.2%), from €996,930 to €945,042

    of which Plant, machinery and equipment: -€28,639

  • Receivables within one year +€19,596

    up €19,596 (+15.1%), from €129,794 to €149,390

    of which Other amounts receivable: +€10,898

  • Stocks and contracts -€18,829

    down €18,829 (-6.2%), from €302,713 to €283,884

Equity and liabilities
  • Reserves +€162,059

    up €162,059 (+67.2%), from €240,998 to €403,057

    of which Distributable reserves: +€162,059

  • Debts after one year -€80,021

    down €80,021 (-9.6%), from €836,254 to €756,232

  • Other debts -€50,976

    down €50,976 (-18.0%), from €283,868 to €232,891

Income statement
  • Staff costs +€11,811

    up €11,811 (+4.0%), from €295,157 to €306,969

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €174,279
Gross operating margin -€2,773
Staff costs -€11,811
Depreciation +€3,402
Other operating charges -€674
Financial charges -€2,201
Taxes +€1,836
Result 2025 €162,059
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€173,004
Investment -€9,767
Financing -€78,885
Cash 2024 €156,482
Net result for the year +€162,059
Depreciation +€61,655
Stocks and contracts +€18,829
Receivables within one year -€19,596
Deferred charges and accrued income -€1,163
Trade debts +€11,065
Tax, wage and social debts -€8,756
Other debts -€50,976
Accrued charges and deferred income -€112
Investment in fixed assets (net) -€9,767
Debts after one year -€80,021
Current portion of long-term debt +€1,136
Cash 2025 €240,834
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,603,574 €1,637,967 +€34,393 +2.1%
Fixed assets 21/28 €1,001,930 €950,042 -€51,887 -5.2%
Tangible fixed assets 22/27 €996,930 €945,042 -€51,887 -5.2%
Land and buildings 22 €677,687 €655,601 -€22,086 -3.3%
Plant, machinery and equipment 23 €318,081 €289,441 -€28,639 -9.0%
Furniture and vehicles 24 €1,162 €0 -€1,162 -100%
Financial fixed assets 28 €5,000 €5,000 = 0.0%
Current assets 29/58 €601,644 €687,925 +€86,281 +14.3%
Stocks and contracts in progress 3 €302,713 €283,884 -€18,829 -6.2%
Stocks 30/36 €302,713 €283,884 -€18,829 -6.2%
Amounts receivable within one year 40/41 €129,794 €149,390 +€19,596 +15.1%
Trade receivables 40 €127,887 €136,585 +€8,698 +6.8%
Other amounts receivable 41 €1,907 €12,805 +€10,898 +571%
Cash at bank and in hand 54/58 €156,482 €240,834 +€84,351 +53.9%
Deferred charges and accrued income 490/1 €12,655 €13,817 +€1,163 +9.2%
Total equity and liabilities 10/49 €1,603,574 €1,637,967 +€34,393 +2.1%
Equity 10/15 €247,198 €409,257 +€162,059 +65.6%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €240,998 €403,057 +€162,059 +67.2%
Tax-exempt reserves 132 €37,500 €37,500 = 0.0%
Distributable reserves 133 €203,498 €365,557 +€162,059 +79.6%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €1,356,376 €1,228,710 -€127,665 -9.4%
Amounts payable after more than one year 17 €836,254 €756,232 -€80,021 -9.6%
Financial debts 170/4 €836,254 €756,232 -€80,021 -9.6%
Amounts payable within one year 42/48 €517,515 €469,984 -€47,532 -9.2%
Current portion of amounts payable after more than one year 42 €78,885 €80,021 +€1,136 +1.4%
Trade debts 44 €111,457 €122,522 +€11,065 +9.9%
Suppliers 440/4 €111,457 €122,522 +€11,065 +9.9%
Taxes, remuneration and social security 45 €43,305 €34,549 -€8,756 -20.2%
Taxes 450/3 €9,839 €502 -€9,336 -94.9%
Remuneration and social security 454/9 €33,466 €34,046 +€580 +1.7%
Other amounts payable 47/48 €283,868 €232,891 -€50,976 -18.0%
Accrued charges and deferred income 492/3 €2,606 €2,494 -€112 -4.3%
Remuneration, social security and pensions 62 €295,157 €306,969 +€11,811 +4.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €65,057 €61,655 -€3,402 -5.2%
Other operating charges 640/8 €374 €1,047 +€674 +180%
Gross operating margin 9900 €622,068 €619,295 -€2,773 -0.4%
Operating profit (loss) 9901 €261,480 €249,624 -€11,856 -4.5%
Financial charges 65/66B €27,363 €29,563 +€2,201 +8.0%
Recurring financial charges 65 €27,363 €29,563 +€2,201 +8.0%
Profit (loss) for the period before taxes 9903 €234,118 €220,061 -€14,057 -6.0%
Income taxes 67/77 €59,839 €58,002 -€1,836 -3.1%
Profit (loss) for the period 9904 €174,279 €162,059 -€12,221 -7.0%
Profit (loss) for the period to be appropriated 9905 €174,279 €162,059 -€12,221 -7.0%

Source: filed annual accounts (NBB), financial years ended 31 August 2024 and 31 August 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.